Frederick Carla A相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Glycemia and Insulin Secretion in Cystic Fibrosis 2 Years After Elexacaftor/Tezacaftor/Ivacaftor: PROMISE-ENDO

囊性纤维化患者接受 Elexacaftor/Tezacaftor/Ivacaftor 治疗 2 年后血糖和胰岛素分泌情况：PROMISE-ENDO 研究

期刊:Journal of Clinical Endocrinology & Metabolism

影响因子:5.1

doi:10.1210/clinem/dgae857

Chan, Christine L; Shirley Bezerra, Meghan; Stefanovski, Darko; Gallop, Robert J; Walega, Rachel; Donaldson, Scott H; Frederick, Carla A; Freedman, Steven D; Gelfond, Daniel; Hoffman, Lucas R; Narkewicz, Michael R; Rowe, Steven M; Sagel, Scott D; Schwarzenberg, Sarah Jane; Solomon, George M; Stalvey, Michael S; Kelly, Andrea

免疫/内分泌

发表日期：2025

文献求助收藏

Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI

Elexacaftor/tezacaftor/ivacaftor 与囊性纤维化患者的胃肠道结局：Promise-GI 报告

期刊:Journal of Cystic Fibrosis

doi:10.1016/j.jcf.2022.10.003

Schwarzenberg, Sarah Jane; Vu, Phuong T; Skalland, Michelle; Hoffman, Lucas R; Pope, Christopher; Gelfond, Daniel; Narkewicz, Michael R; Nichols, David P; Heltshe, Sonya L; Donaldson, Scott H; Frederick, Carla A; Kelly, Andrea; Pittman, Jessica E; Ratjen, Felix; Rosenfeld, Margaret; Sagel, Scott D; Solomon, George M; Stalvey, Michael S; Clancy, John P; Rowe, Steven M; Freedman, Steven D

发表日期：2023

文献求助收藏

Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial

Elexacaftor/Tezacaftor/Ivacaftor治疗囊性纤维化患者的临床疗效：一项临床试验

期刊:American Journal of Respiratory and Critical Care Medicine

影响因子:19.4

doi:10.1164/rccm.202108-1986OC

Nichols, David P; Paynter, Alex C; Heltshe, Sonya L; Donaldson, Scott H; Frederick, Carla A; Freedman, Steven D; Gelfond, Daniel; Hoffman, Lucas R; Kelly, Andrea; Narkewicz, Michael R; Pittman, Jessica E; Ratjen, Felix; Rosenfeld, Margaret; Sagel, Scott D; Schwarzenberg, Sarah Jane; Singh, Pradeep K; Solomon, George M; Stalvey, Michael S; Clancy, John P; Kirby, Shannon; Van Dalfsen, Jill M; Kloster, Margaret H; Rowe, Steven M

发表日期：2022

文献求助收藏

PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy

承诺：与囊性纤维化社群合作，了解接受高效CFTR调节剂治疗的患者在临床和研究方面不断涌现的需求。

期刊:Journal of Cystic Fibrosis

doi:10.1016/j.jcf.2021.02.003

Nichols, Dave P; Donaldson, Scott H; Frederick, Carla A; Freedman, Steven D; Gelfond, Daniel; Hoffman, Lucas R; Kelly, Andrea; Narkewicz, Michael R; Pittman, Jessica E; Ratjen, Felix; Sagel, Scott D; Rosenfeld, Margaret; Schwarzenberg, Sarah Jane; Singh, Pradeep K; Solomon, George M; Stalvey, Michael S; Kirby, Shannon; VanDalfsen, Jill M; Clancy, John P; Rowe, Steven M

发表日期：2021

文献求助收藏

Vancomycin Versus Vancomycin Plus Rifampin for the Treatment of Acute Pulmonary Exacerbations of Cystic Fibrosis

万古霉素与万古霉素联合利福平治疗囊性纤维化急性肺部加重的比较

期刊:Journal of Pediatric Pharmacology and Therapeutics

doi:10.5863/1551-6776-23.2.125

Fusco, Nicholas M; Meaney, Calvin J; Wells, Corey; Frederick, Carla A; Prescott, William A Jr

发表日期：2018

文献求助收藏

Clinical and molecular characterization of S1118F-CFTR.

S1118F-CFTR 的临床和分子特征

期刊:Pediatric Pulmonology

影响因子:2.3

doi:10.1002/ppul.21092

Penmatsa Himabindu, Frederick Carla A, Nekkalapu Sunitha, Conoley Veronica G, Zhang Weiqiang, Li Chunying, Kappes John, Stokes Dennis C, Naren Anjaparavanda P

发表日期：2009

文献求助收藏